The collaboration seeks to leverage AI to enhance the precision and effectiveness of heart disease detection and monitoring, according to an Aug. 8 news release from SandboxAQ.
Under the collaboration, Mayo Clinic researchers will evaluate SandboxAQ’s MCG imaging system, known as CardiAQ. This mobile device utilizes magnetic sensors and advanced AI algorithms to offer rapid, radiation-free visualization of the heart’s magnetic signals.
The partnership’s initial phase will focus on a clinical study comparing MCG data with angiography findings and will be conducted at Mayo Clinic throughout 2024 and 2025. The study aims to explore the potential of MCG technology in improving cardiac diagnostics, according to the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
